AVALANCHE BIOTECHNOLOGIES IN's ticker is AAVL and the CUSIP is 05337G107. A total of 94 filers reported holding AVALANCHE BIOTECHNOLOGIES IN in Q3 2015. The put-call ratio across all filers is 2.32 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2016 | $2,131,000 | -41.8% | 412,191 | +7.1% | 0.00% | -100.0% |
| Q4 2015 | $3,664,000 | +136.4% | 384,835 | +104.6% | 0.00% | – |
| Q3 2015 | $1,550,000 | -87.6% | 188,101 | -75.5% | 0.00% | -100.0% |
| Q2 2015 | $12,485,000 | +31.5% | 768,797 | +337.2% | 0.00% | +33.3% |
| Q4 2014 | $9,496,000 | +42.2% | 175,859 | -9.9% | 0.00% | +50.0% |
| Q3 2014 | $6,677,000 | – | 195,283 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|